Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Clinuvel Pharmaceuticals Limited is a biopharmaceutical company. The Company is focused on developing drugs for the treatment of a range of severe skin disorders. Its lead compound, SCENESSE (afamelanotide 16 milligrams), prevents phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company focuses at preventing the symptoms of skin diseases related to the exposure to harmful ultra violet (UV) radiation and at repigmentation of the skin due to a number of depigmentation disorders. SCENESSE has completed Phase II and III trials in the United States and Europe, and has been granted marketing authorization by the European Commission for adults with EPP. It has operations in Europe, the United States and Singapore. SCENESSE acts by increasing the levels of melanin in the skin and shields against UV radiation (UVR) and sunlight. SCENESSE is delivered via a subcutaneous dissolving implant.

Zengen, Inc. develops and commercializes peptide drugs. Its products help to prevent infection and inflammation through application of its patented peptide technologies. The company's technologies help to modulates inflammatory and immune responses. Zengen was founded in 1999 and is located in Woodland Hills, CA

Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.

Science & Technology Corp. provides scientific, technical, and engineering services. The firm Specializes in defense chemical and biological research, test and evaluation, range support services, earth and space sciences, polar technologies, aerospace engineering and information systems engineering and support. The company was founded in 1979 and is headquartered in Hampton, VA.

TheraTech, Inc. manufactures and distributes medical devices. The company was founded by Chick Sanford & Dinesh C. Patel in January, 1985 and is located in Hopkins, MN

LG H&H Co., Ltd. engages in the production and sale of household goods and cosmetic products. It operates through following divisions Beauty, Health and Refreshment businesses. The Beauty business division provides anti-aging cosmetic products. The Health division markets healthcare, skincare and household products. The Refreshment division provides soda, juice, energy drinks and other beverages. The company was founded on April 3, 2001 and is headquartered in Seoul, South Korea.

The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA.

The National Skin Centre is a subsidiary of the Health Corporation of Singapore Private Limited that is owned by the Ministry of Health. Incorporated on 9 June 1988, it is the major specialist medical centre in Singapore providing outpatient dermatological treatment, seeing about 950 patients a day.

Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for treating diseases with significant unmet medical needs and commercial potential. Their programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Their primary product in clinical development is bremelanotide for treating female sexual dysfunction (FSD). In addition, they have drug candidates or development programs for obesity, erectile dysfunction, pulmonary diseases, cardiovascular diseases, and inflammatory diseases. Their current focus is on the design and development of receptor-selective melanocortin agonists for inflammation and autoimmune conditions, with a focus on ocular diseases. Their therapeutics work by activating endogenous melanocortin pathways to resolve damaging inflammation and allow affected tissues time to heal. Research has shown melanocortin agonists can prevent and reverse inflammation in disease models, including in the eyes and intestine—two of their targeted areas.

Provincial Health Services Authority (PHSA) is a publicly funded health service provider in the province of British Columbia. Other health authorities in the province have a regional jurisdiction. PHSA is unique in Canada as the only health authority having a province-wide mandate for specialized health services. Services are provided either directly through PHSA agencies or through funding or collaboration with regional health authorities.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Miwon Commercial Co., Ltd. engages in the manufacture of chemicals such as sulphuric acid and sulphur powder. It operates through the following business areas: Personal Care Ingredients, Electronic Chemicals, and Polymer Additives. The Personal Care Ingredients business provides surfactants, conditioning polymers, styling resin, cosmeceutical active ingredients, and others. The Electronic Chemicals business markets photo active compounds, polymer acrylate binder or novalak resin, and functional chemicals and additive. The Polymer Additives business sells antioxidants and ultraviolet stabilizers. The company was founded on November 3, 1959 and is headquartered in Ansan-si, South Korea.

Guangzhou Hongbaoyuan Biotechnology Co., Ltd., established on 2017-04-12, Business scope includes health food manufacturing;Health food wholesale(Specific business items are<food business license>prevail);Health Food Retail(Specific business items are<food business license>prevail);Natural science research and experimental development;Human Science Research,to develop;Health Sciences Program Research,to develop;Medical Research and Experimental Development;Biomedical Technology Research;Regenerative Medicine Anti-aging Research Services;Gene drug development;Biotechnology Development Services;Biotechnology Consulting,communication service;Human Science Research Achievement Transfer Service;Research and development and technology transfer of health science;Health Sciences Program Research Transfer;Technology Promotion of Research Results of Health Science Projects;Research and development of biological products(Does not include licensed operations);Sales of Biological Products(Does not include licensed operations);Commodity retail trade(Except for licensed and approved products);Commodity wholesale trade(Except for licensed and approved products);Wholesale of cosmetics and hygiene products;Cosmetic Manufacturing;Retailing of cosmetics and hygiene products;Internet Merchandise Sales(Except for licensed and approved products);Internet commodity retail(Except for licensed and approved products);Biotechnology Transfer Services;Research and development of biodiagnostic reagents and kits(Does not include license approval items);Sales of biological diagnostic reagents and kits(Does not include license approval items);

Zhongshan Jiadanting Commodity Co., Ltd., established on 2001-12-26, Business scope includes sales:cosmetic[General liquid unit(Hair Cleansing,skin care water,Jelly),cream lotion unit(Hair Cleansing,Hair category)](No eye skin care,Baby & Kids Hair Care),liquid disinfectant,liquid resistance(suppress)Bacterial preparation(suppositories,except soap),fabric cleaner,Household cleaning and care agent,toothpaste,toothbrush,body powder,toilet water,perfume,hair cream,sanitary wipes,Daily necessities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henkel AG & Co. KGaA engages in the production, sale, and distribution of home and beauty care products. The firm also provides adhesive technology solutions. It operates through the Adhesive Technologies and Consumer Brands segments. The Adhesive Technologies segment sells adhesives, sealants, and functional coatings for consumers, craftsmen, and industrial applications. The Consumer Brands segment offers branded products for consumers and professional applications for the hairdressing business that includes products for hair care, styling and coloring, as well as detergents and fabric softeners. The company was founded by Fritz Henkel on September 26, 1876 and is headquartered in Dusseldorf, Germany.